CA-A Cancer Journal for Clinicians

Papers
(The TQCC of CA-A Cancer Journal for Clinicians is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Breast cancer in a transgender man13986
Minority groups underrepresented in hematologic cancer trials12779
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey12364
Cancer treatment and survivorship statistics, 20256708
Cancer statistics 2024: All hands on deck2021
Near majority of adults favor R ratings for films with smoking1946
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians1574
Issue Information1197
503
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer433
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types360
Most patients with cancer are not undergoing germline genetic testing334
Multicancer detection tests: What we know and what we don’t know319
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies240
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach182
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future167
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine165
163
Issue Information114
More care needed for cancer caregivers98
Health insurance status and cancer stage at diagnosis and survival in the United States96
Reviewer acknowledgement 202592
92
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial82
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review81
The evolving landscape of tissue‐agnostic therapies in precision oncology80
Study assesses normal tissue effects after axillary radiotherapy for early breast cancer78
Lung cancer screening guidelines: Smoking matters, not quitting71
Medicaid expansion increases survival for patients with cancer71
Study identifies risk factors that may lead to secondary cancers68
Overlooked barriers to implementation of geriatric assessment68
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma61
Does distance deter male fertility preservation?58
Interventional gastroenterology in oncology57
The contemporary management of cancers of the sinonasal tract in adults52
Prostate cancer statistics, 202551
Issue Information41
Issue Information41
Screening for lung cancer40
Cancer survivors at greater risk for bone fractures late in life39
From medical student to Editor: A note of thanks37
Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline34
Issue Information34
Bilateral mastectomy may not reduce mortality risk34
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance32
Breast Cancer Statistics, 202230
Prevention of device‐related infections in patients with cancer: Current practice and future horizons27
Issue Information27
Clinical management of metastatic colorectal cancer in the era of precision medicine27
Chemotherapy‐induced taste changes affect nutrition, quality of life27
American Cancer Society nutrition and physical activity guideline for cancer survivors25
Cancer treatment and survivorship statistics, 202225
Is active surveillance an alternative to surgery for some patients with esophageal cancer?24
22
Issue Information21
Better communication is key for quality‐of‐life improvement in low‐income and minority patients20
20
Cancer misinformation on social media19
17
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries17
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors17
Key issues face AI deployment in cancer care17
0.18285894393921